Campbell Chad Thomas's Form 4 filing
Angiodynamics Inc (ANGO) · filed Jul 22, 2026
- Accession no.
- 0001140361-26-029331
- Filed
- Jul 22, 2026, 8:06 PM ET
- Trade date
- Jul 15, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Campbell Chad ThomasCIK 0001706852 | Officer (SVP/GM, Vascular Access) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | AGrant or awardAcquired | +16,081 | $0.00 | $0 | 104,540 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | AGrant or awardAcquired | +16,081 | $0.00 | $0 | 16,081 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.